CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
University of Copenhagen
Copenhague, DinamarcaPublications in collaboration with researchers from University of Copenhagen (7)
2024
-
Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review
Frontiers in Immunology, Vol. 15
2023
-
European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
European Journal of Neurology, Vol. 30, Núm. 8, pp. 2144-2176
-
Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summary
Neurodegenerative Disease Management, Vol. 13, Núm. 1, pp. 5-13
2021
-
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice
Therapeutic Advances in Neurological Disorders, Vol. 14
2018
-
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
The Lancet Neurology, Vol. 17, Núm. 5, pp. 405-415
-
Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
Multiple Sclerosis Journal, Vol. 24, Núm. 5, pp. 590-603
2016
-
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: A cohort study
The Lancet Neurology, Vol. 15, Núm. 6, pp. 574-584